MMTec, Inc.(MTC)Earnings, Financials & Key Ratios

MTC•NASDAQ

$2.39

Price updated Jul 7, 2026

SectorTechnology IndustryApplication Software Sub-IndustryFinancial services and insurance software

AboutMMTec, Inc., together with its subsidiaries, develops and deploys platforms that enable financial institutions to engage in securities market transactions and settlements worldwide. The company operates in two segments, Gujia, MM Future, MMBD Advisory and HC Securities; and MM Global. It offers Internet-based securities solutions comprising Securities Dealers Trading System, which supports securities registration and clearing, account management, risk management, trading and execution, and third party access middleware; Private Fund Investment Management System that supports multi-account management, fund valuation, risk management, quantitative trading access, liquidation, and requisition management; and Mobile Transaction Individual Client System and PC Client System for Apple IOS, Android, PC, and Web applications. The company enables its customers to white label its trading interface, as well as select modular functionalities. It serves hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms. The company was founded in 2015 and is headquartered in Beijing, the People's Republic of China.Show more

Revenue-$20M-1196.4%
EBITDA-$49M+47.6%
Net Income-$56M+38.5%
EPS (Diluted)-1.05+71.2%
Gross Margin103.91%+35.6%
EBITDA Margin238.7%+104.8%
Operating Margin239.11%+104.8%
Net Margin273.74%+105.6%
ROE-272.72%-117.6%

MTC Price & Volume

MMTec, Inc. (MTC) stock price & volume — 10-year historical chart

Loading chart...

Catastrophic Revenue Collapse Signals Existential Business Risk

Investment Thesis • Updated 2025Q4

VerdictNegative: The company's fundamental instability is underscored by a $124.0 million retained earnings deficit and a consistent inability to generate positive free cash flow

Growth:Contracting

Profitability:Negative

Financial:Vulnerable

Cash Flow:Burning

Primary Risk:Existential regulatory and solvency

Key Thesis Takeaways

MMTec, Inc.
faces a severe existential crisis characterized by a total erosion of its core revenue base, which plummeted to negative $20.48 million in the most recent TTM period.
The company's historical reliance on acquisitions, evidenced by the complete write-off of $106.9 million in goodwill, has failed to generate sustainable shareholder value or operational stability.
Investors should exercise extreme caution as the firm's $124.0 million retained earnings deficit and persistent cash burn suggest a high probability of continued insolvency risk.

Verdict Logic

which totaled negative $2.0 million in 2025Q4.

MTC Growth Metrics

MMTec, Inc. (MTC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-

5 Years-

3 Years-

TTM-1045.45%

Profit CAGR

10 Years-

5 Years-

3 Years-

TTM-954.57%

EPS CAGR

10 Years-

5 Years-

3 Years-

TTM-141.35%

Return on Capital

10 Years-81.03%

5 Years-70.17%

3 Years-74.15%

Last Year-128.33%

MTC Recent Earnings

MMTec, Inc. (MTC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

Q2 2026Latest

Apr 8, 2026

Metric

Actual

Est

EPS

$0.24

—

Rev

—

Q3 2025

Jul 9, 2025

Metric

Actual

Est

EPS

$1.84

—

Rev

$807,500

—

Q4 2024

Dec 31, 2024

Metric

Actual

Est

EPS

$2.50

—

Rev

$2M

—

Q3 2024

Jul 30, 2024

Metric

Actual

Est

EPS

$1.14

—

Rev

—

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Apr 8, 2026	$0.24	—
Q3 2025	Jul 9, 2025	$1.84	$807,500
Q4 2024	Dec 31, 2024	$2.50	$2M
Q3 2024	Jul 30, 2024	$1.14	—

Based on last 12 quarters of dataView full earnings history →

Latest MTC News

Recent stock market news and headlines for MMTec, Inc. (MTC)

Business Wire·Jun 23, 2026

Javelin Biotech and Pfizer Announce Landmark Publication Demonstrating Clinical PK Predictions Using Multi-Tissue Chip Platform

BILLERICA, Mass.--(BUSINESS WIRE)--Javelin Biotech today announced a landmark scientific publication, titled "Interconnected multi-microphysiological systems and PBPK modeling for predicting human pharmacokinetics”, in the "Breakthrough" special issue of Lab on a Chip. The study details a liver-centric multi-tissue chip (MTC) platform designed to capture the complex pharmacokinetic (PK) profiles of small-molecule drugs. The research marks a significant demonstration of how combinatorial NAMs en.

Peers Comparison

Key metrics vs top competitors for MMTec, Inc. (MTC)

Full Screener →

Company	Price	Market Cap	P/E Ratio	Rev Growth (1Y)	Net Margin	ROE	Div Yield
MTCMMTec, Inc.Current	$2.39	$94.11M	-2.28	-1196.43%	273.74%	-272.72%	—
TIGRUP Fintech Holding Ltd. Sponsored ADR Class A	$4.52	$838.08M	4.91	56.74%	24.18%	17.64%	—
FUTUFutu Holdings Limited	$94.03	$13.12B	9.21	67.83%	44.27%	26.38%	—
LSPDLightspeed Commerce Inc.	$10.59	$1.46B	-10.28	13.95%	-11.79%	-9.59%	—
PFISPeoples Financial Services Corp.	$67.05	$671.23M	11.40	22.26%	20.68%	11.5%	—
IBKRInteractive Brokers Group, Inc.	$94.57	$41.93B	42.60	9.83%	9.77%	5.21%	—

Compare MTC vs Peers

MMTec, Inc. (MTC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs TIGR

Most directly comparable listed peer for MTC.

Scale Benchmark

vs MSFT

Larger-name benchmark to compare MTC against a more recognizable public peer.

Peer Set

Compare Top 5

vs TIGR, FUTU, LSPD, PFIS

Get notified when MTC posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

MTC Frequently Asked Questions

MMTec, Inc. (MTC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

What is MMTec, Inc.'s revenue?

MMTec, Inc. (MTC) reported $-18.6M in revenue for fiscal year 2025.

How fast is MMTec, Inc. growing?

MMTec, Inc. (MTC) saw revenue decline by 1196.4% over the past year.

Is MTC profitable?

MMTec, Inc. (MTC) reported a net loss of $147.2M for fiscal year 2025.

Dividend & Returns

What is MTC's return on equity?

MMTec, Inc. (MTC) has a return on equity (ROE) of -272.7%. Negative ROE indicates the company is unprofitable.

What is MMTec, Inc.'s free cash flow?

MMTec, Inc. (MTC) had negative free cash flow of $3.0M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in MTC back in 2016?

Total return calculator · dividends reinvested · 10+ years of data

See returns →

Quarter

Date

EPS (Act vs Est)

Revenue (Act vs Est)

Q2 2026Latest

Apr 8, 2026

$0.24

—

Q3 2025

Jul 9, 2025

$1.84

$807,500

Q4 2024

Dec 31, 2024

$2.50

$2M

Q3 2024

Jul 30, 2024

$1.14

—

Company

Price

Market Cap

P/E Ratio

Rev Growth (1Y)

Net Margin

ROE

Div Yield

MTCMMTec, Inc.Current

$2.39

$94.11M

-2.28

-1196.43%

273.74%

-272.72%

—

TIGRUP Fintech Holding Ltd. Sponsored ADR Class A

$4.52

$838.08M

4.91

56.74%

24.18%

17.64%

—

FUTUFutu Holdings Limited

$94.03

$13.12B

9.21

67.83%

44.27%

26.38%

—

LSPDLightspeed Commerce Inc.

$10.59

$1.46B

-10.28

13.95%

-11.79%

-9.59%

—

PFISPeoples Financial Services Corp.

$67.05

$671.23M

11.40

22.26%

20.68%

11.5%

—

IBKRInteractive Brokers Group, Inc.

$94.57

$41.93B

42.60

9.83%

9.77%

5.21%

—